In terms of patient survival, higher PRK1 expression did not significantly correlate with poorer survival across all breast cancer patients or with a particular subtype (Fig. 4B, PRK1 panel); indeed, across all breast cancer patients and those with Basal-like and Her2 enriched tumours, higher PRK1 expression correlated with better survival. Here, ERBB2 is linked to neoplasm.